ESOPApr 14, 2026, 12:48 PM
Vistagen Grants Stock Options to Employees & Executives
AI Summary
Vistagen Therapeutics' Compensation Committee approved retention stock option awards for all company employees, including five key executives. Each executive, including the CEO and CFO, received options to purchase up to 75,000 shares at an exercise price of $0.5358 per share. These options will vest over two years, with 25% vesting after six months and subsequent 25% installments every six months thereafter, aiming to incentivize and retain talent.
Key Highlights
- Vistagen granted retention stock options to all employees.
- Five executives, including CEO and CFO, received options for up to 75,000 shares each.
- Options have an exercise price of $0.5358 per share.
- Options vest over two years, with 25% vesting every six months.
Price Impact
More from VTGN